These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23789127)
1. Reply to Townes-Anderson: RPE65 gene therapy does not alter the natural history of retinal degeneration. Cideciyan AV; Jacobson SG; Beltran WA; Hauswirth WW; Aguirre GD Proc Natl Acad Sci U S A; 2013 May; 110(19):E1706. PubMed ID: 23789127 [No Abstract] [Full Text] [Related]
2. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Cideciyan AV; Jacobson SG; Beltran WA; Sumaroka A; Swider M; Iwabe S; Roman AJ; Olivares MB; Schwartz SB; Komáromy AM; Hauswirth WW; Aguirre GD Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E517-25. PubMed ID: 23341635 [TBL] [Abstract][Full Text] [Related]
3. Available Evidence on Leber Congenital Amaurosis and Gene Therapy. Alkharashi M; Fulton AB Semin Ophthalmol; 2017; 32(1):14-21. PubMed ID: 27686653 [TBL] [Abstract][Full Text] [Related]
4. Increased levels of gene therapy may not be beneficial in retinal disease. Townes-Anderson E Proc Natl Acad Sci U S A; 2013 May; 110(19):E1705. PubMed ID: 23553840 [No Abstract] [Full Text] [Related]
5. [Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial]. Chacón-Camacho ÓF; Zenteno JC Gac Med Mex; 2017; 153(2):276-278. PubMed ID: 28474714 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis. Rakoczy EP; Narfström K Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304 [TBL] [Abstract][Full Text] [Related]
9. Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis. Le Meur G; Lebranchu P; Billaud F; Adjali O; Schmitt S; Bézieau S; Péréon Y; Valabregue R; Ivan C; Darmon C; Moullier P; Rolling F; Weber M Mol Ther; 2018 Jan; 26(1):256-268. PubMed ID: 29033008 [TBL] [Abstract][Full Text] [Related]
10. Utility of In Vitro Mutagenesis of RPE65 Protein for Verification of Mutational Pathogenicity Before Gene Therapy. Yang U; Gentleman S; Gai X; Gorin MB; Borchert MS; Lee TC; Villanueva A; Koenekoop R; Maguire AM; Bennett J; Redmond TM; Nagiel A JAMA Ophthalmol; 2019 Dec; 137(12):1381-1388. PubMed ID: 31580392 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for Leber congenital amaurosis: advances and future directions. Hufnagel RB; Ahmed ZM; Corrêa ZM; Sisk RA Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1117-28. PubMed ID: 22644094 [TBL] [Abstract][Full Text] [Related]
12. The Status of RPE65 Gene Therapy Trials: Safety and Efficacy. Pierce EA; Bennett J Cold Spring Harb Perspect Med; 2015 Jan; 5(9):a017285. PubMed ID: 25635059 [TBL] [Abstract][Full Text] [Related]
13. Dog models for blinding inherited retinal dystrophies. Petersen-Jones SM; Komáromy AM Hum Gene Ther Clin Dev; 2015 Mar; 26(1):15-26. PubMed ID: 25671556 [TBL] [Abstract][Full Text] [Related]
14. RPE65 gene therapy slows cone loss in Rpe65-deficient dogs. Mowat FM; Breuwer AR; Bartoe JT; Annear MJ; Zhang Z; Smith AJ; Bainbridge JW; Petersen-Jones SM; Ali RR Gene Ther; 2013 May; 20(5):545-55. PubMed ID: 22951453 [TBL] [Abstract][Full Text] [Related]
15. Long-term effect of gene therapy on Leber's congenital amaurosis. Bainbridge JW; Mehat MS; Sundaram V; Robbie SJ; Barker SE; Ripamonti C; Georgiadis A; Mowat FM; Beattie SG; Gardner PJ; Feathers KL; Luong VA; Yzer S; Balaggan K; Viswanathan A; de Ravel TJ; Casteels I; Holder GE; Tyler N; Fitzke FW; Weleber RG; Nardini M; Moore AT; Thompson DA; Petersen-Jones SM; Michaelides M; van den Born LI; Stockman A; Smith AJ; Rubin G; Ali RR N Engl J Med; 2015 May; 372(20):1887-97. PubMed ID: 25938638 [TBL] [Abstract][Full Text] [Related]
17. Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65. Georgiadis A; Duran Y; Ribeiro J; Abelleira-Hervas L; Robbie SJ; Sünkel-Laing B; Fourali S; Gonzalez-Cordero A; Cristante E; Michaelides M; Bainbridge JW; Smith AJ; Ali RR Gene Ther; 2016 Dec; 23(12):857-862. PubMed ID: 27653967 [TBL] [Abstract][Full Text] [Related]
18. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis. Hussain RM; Tran KD; Maguire AM; Berrocal AM Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202 [TBL] [Abstract][Full Text] [Related]
19. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Cideciyan AV Prog Retin Eye Res; 2010 Sep; 29(5):398-427. PubMed ID: 20399883 [TBL] [Abstract][Full Text] [Related]